Loring Wolcott & Coolidge Fiduciary Advisors LLP Abb Vie Inc. Transaction History

Loring Wolcott & Coolidge Fiduciary Advisors LLP

  • $11.2 Billion
  • Q3 2025

A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Abb Vie Inc. stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 64,430 shares of ABBV stock, worth $15.1 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
64,430
Previous 60,167 7.09%
Holding current value
$15.1 Million
Previous $11.2 Million 33.58%
% of portfolio
0.13%
Previous 0.1%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 24, 2025
BUY
$184.85 - $231.54 $788,015 - $987,055
4,263 Added 7.09%
64,430 $14.9 Million
Q2 2025

Jul 30, 2025
SELL
$170.16 - $206.27 $39,477 - $47,854
-232 Reduced 0.38%
60,167 $11.2 Million
Q1 2025

Apr 24, 2025
BUY
$169.2 - $216.66 $235,864 - $302,024
1,394 Added 2.36%
60,399 $12.7 Million
Q4 2024

Jan 28, 2025
SELL
$164.99 - $203.87 $176,704 - $218,344
-1,071 Reduced 1.78%
59,005 $10.5 Million
Q3 2024

Oct 25, 2024
BUY
$163.84 - $199.33 $10,321 - $12,557
63 Added 0.1%
60,076 $11.9 Million
Q2 2024

Jul 17, 2024
BUY
$154.79 - $180.76 $254,319 - $296,988
1,643 Added 2.81%
60,013 $10.3 Million
Q1 2024

Apr 23, 2024
SELL
$159.82 - $182.1 $137,125 - $156,241
-858 Reduced 1.45%
58,370 $10.6 Million
Q4 2023

Feb 01, 2024
SELL
$137.6 - $154.97 $277,401 - $312,419
-2,016 Reduced 3.29%
59,228 $9.18 Million
Q3 2023

Nov 03, 2023
SELL
$133.59 - $154.65 $543,043 - $628,652
-4,065 Reduced 6.22%
61,244 $9.13 Million
Q2 2023

Aug 01, 2023
SELL
$132.51 - $164.9 $44,788 - $55,736
-338 Reduced 0.51%
65,309 $8.8 Million
Q1 2023

May 02, 2023
SELL
$144.61 - $166.54 $239,763 - $276,123
-1,658 Reduced 2.46%
65,647 $10.5 Million
Q4 2022

Mar 02, 2023
BUY
$138.31 - $165.87 $6,915 - $8,293
50 Added 0.07%
67,305 $10.9 Million
Q4 2022

Feb 14, 2023
BUY
$138.31 - $165.87 $31,811 - $38,150
230 Added 0.34%
67,255 $9.99 Million
Q3 2022

Oct 25, 2022
SELL
$134.21 - $153.93 $41,068 - $47,102
-306 Reduced 0.45%
67,025 $9 Million
Q2 2022

Jul 26, 2022
BUY
$137.62 - $174.96 $103,490 - $131,569
752 Added 1.13%
67,331 $10.3 Million
Q1 2022

Apr 13, 2022
SELL
$131.98 - $163.75 $430,650 - $534,316
-3,263 Reduced 4.67%
66,579 $10.8 Million
Q4 2021

Feb 14, 2022
SELL
$107.43 - $135.93 $668,107 - $845,348
-6,219 Reduced 8.18%
69,842 $9.46 Million
Q3 2021

Nov 12, 2021
BUY
$106.4 - $120.78 $58,520 - $66,429
550 Added 0.73%
76,061 $8.21 Million
Q2 2021

Aug 13, 2021
BUY
$105.21 - $117.21 $145,505 - $162,101
1,383 Added 1.87%
75,511 $8.51 Million
Q1 2021

Apr 14, 2021
SELL
$102.3 - $112.62 $618,403 - $680,787
-6,045 Reduced 7.54%
74,128 $8.02 Million
Q4 2020

Jan 14, 2021
SELL
$80.49 - $108.67 $20,927 - $28,254
-260 Reduced 0.32%
80,173 $8.59 Million
Q3 2020

Oct 15, 2020
SELL
$85.91 - $100.83 $281,870 - $330,823
-3,281 Reduced 3.92%
80,433 $7.05 Million
Q2 2020

Jul 30, 2020
SELL
$73.37 - $98.18 $86,209 - $115,361
-1,175 Reduced 1.38%
83,714 $8.22 Million
Q1 2020

Apr 15, 2020
SELL
$64.5 - $97.79 $238,327 - $361,334
-3,695 Reduced 4.17%
84,889 $6.47 Million
Q4 2019

Jan 22, 2020
SELL
$72.13 - $90.25 $346,296 - $433,290
-4,801 Reduced 5.14%
88,584 $7.84 Million
Q3 2019

Nov 05, 2019
BUY
$62.98 - $75.72 $92,832 - $111,611
1,474 Added 1.6%
93,385 $7.07 Million
Q2 2019

Aug 09, 2019
SELL
$65.7 - $83.98 $169,046 - $216,080
-2,573 Reduced 2.72%
91,911 $6.68 Million
Q1 2019

Apr 08, 2019
SELL
$77.14 - $90.79 $497,861 - $585,958
-6,454 Reduced 6.39%
94,484 $7.61 Million
Q4 2018

Feb 13, 2019
BUY
$77.85 - $96.01 $101,905 - $125,677
1,309 Added 1.31%
100,938 $9.31 Million
Q3 2018

Oct 31, 2018
SELL
$88.91 - $98.84 $519,856 - $577,917
-5,847 Reduced 5.54%
99,629 $9.42 Million
Q2 2018

Aug 07, 2018
SELL
$89.78 - $106.23 $488,582 - $578,103
-5,442 Reduced 4.91%
105,476 $9.77 Million
Q1 2018

Apr 20, 2018
SELL
$92.01 - $123.21 $28,155 - $37,702
-306 Reduced 0.28%
110,918 $10.5 Million
Q4 2017

Feb 08, 2018
SELL
$89.56 - $98.21 $28,569 - $31,328
-319 Reduced 0.29%
111,224 $10.8 Million
Q3 2017

Oct 27, 2017
SELL
$69.85 - $89.22 $121,399 - $155,064
-1,738 Reduced 1.53%
111,543 $9.91 Million
Q2 2017

Aug 07, 2017
BUY
N/A
113,281
113,281 $0

Others Institutions Holding ABBV

# of Institutions
4,481
Shares Held
1.28B
Call Options Held
17.1M
Put Options Held
15.4M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $414B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Loring Wolcott & Coolidge Fiduciary Advisors LLP Portfolio

Follow Loring Wolcott & Coolidge Fiduciary Advisors LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email